Table 3.
Evaluation of quality of life in physical sphere (SF-36 PCS) and mental sphere (SF-36 MCA), and sex, age, and duration of disease in OA and RA
| Variables studied | SF-36
|
|||||||
|---|---|---|---|---|---|---|---|---|
| Quality of life in PCS (0–100)
|
Quality of life in MCS (0–100)
|
|||||||
| OA, mean ± SD 42.39±18.73
|
RA, mean ± SD 37.36±14.57
|
OA, mean ± SD 47.65±21.44
|
RA, mean ± SD 44.39±20.81
|
|||||
| Mean ± SD | F-statistic#/P-value rs&/P-value | Mean ± SD | F-statistic#/P-value rs&/P-value | Mean ± SD | F-statistic#/P-value rs&/P-value | Mean ± SD | F-statistic#/P-value rs&/P-value | |
| Sex | ||||||||
| F | 38.70±16.50 | #10.01 (0.001) | 35.51±12.58 | #3.863 (0.052) | 44.00±21.32 | #7.396 (0.007) | 41.34±17.85 | #4.932 (0.028) |
| M | 47.00±20.36 | 41.67±17.90 | 52.51±20.82 | 51.23±17.85 | ||||
| Age (years) | ||||||||
| 40–60 | 46.88±20.91 | #4.558 (0.011)&−0.177 (0.012) | 40.40±18.82 | #2.195 (0.116)&−0.234 (0.019) | 52.16±21.97 | #3.726 (0.025)&−0.185 (0.008) | 49.31±20.45 | #1.720 (0.184)&−0.208 (0.038) |
| 61–76 | 39.25±15.92 | 37.94±14.60 | 45.28±19.66 | 43.68±20.39 | ||||
| ≥77 | 38.36±16.71 | 32.33±13.41 | 42.16±21.98 | 39.01±21.43 | ||||
| Duration of diseases (years) | ||||||||
| 0–5 | 51.15±21.12 | #8.760 (<0.001) | 41.80±19.46 | #3.170 (0.025) | 55.37±20.21 | #7.585 (<0.001) | 49.08±24.09 | #0.486 (0.692) |
| 6–10 | 43.89±19.87 | 41.08±13.39 | 52.50±22.18 | 43.86±18.03 | ||||
| >10 | 38.14±15.81 | 33.52±11.39 | 42.63±20.46 | 41.03±21.38 | ||||
Note:
#
The univariate ANOVA for independent groups, F-statistic,
&
Spearman correlation coefficient rs.
Abbreviations: ANOVA, analysis of variance; F, female; M, male; MCS, mental sphere; PCS, physical sphere; SF-36, 36-item short form health survey; OA, osteoarthritis; RA, rheumatoid arthritis; SD, standard deviation.